Search PDMR transactions

Notifier
Name of person with notification obligation
Yilmaz Mahshid
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Yilmaz Mahshid
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Egetis Therapeutics AB (publ)
Issuer´s LEI code
549300RZCKGWRUBPMY22
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Egetis Therapeutics AB SE0003815604 Disposal 74,769 Quantity 6.79 SEK 07/01/2025 NASDAQ STOCKHOLM AB
Share Egetis Therapeutics AB SE0003815604 Disposal 98,567 Quantity 6.63 SEK 08/01/2025 NASDAQ STOCKHOLM AB
Share Egetis Therapeutics AB SE0003815604 Disposal 39,753 Quantity 6.75 SEK 09/01/2025 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Egetis Therapeutics AB SE0003815604 Disposal 07/01/2025 NASDAQ STOCKHOLM AB 74,769 (Quantity) 6.79 SEK
Egetis Therapeutics AB SE0003815604 Disposal 08/01/2025 NASDAQ STOCKHOLM AB 98,567 (Quantity) 6.63 SEK
Egetis Therapeutics AB SE0003815604 Disposal 09/01/2025 NASDAQ STOCKHOLM AB 39,753 (Quantity) 6.75 SEK
Total: 213,089
<< Back